Kimberly Gentile
Chief Tech/Sci/R&D Officer bij BIOHAVEN LTD.
Vermogen: 5 M $ op 31-03-2024
Profiel
Mevrouw Kimberly Gentile is Senior Vice President-Clinical Operations bij Biohaven Pharmaceutical Holding Co. Ltd. en een Operations Director bij Portage Pharmaceutical Ltd. Mevrouw Gentile was voorheen werkzaam als Associate Director bij Bristol Myers Squibb Co. en als Senior Manager-Clinical Trail bij SCIREX Corp. Zij behaalde haar doctoraal aan de Salem State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BIOHAVEN LTD.
0.12% | 04-03-2024 | 95 969 ( 0.12% ) | 5 M $ | 31-03-2024 |
Actieve functies van Kimberly Gentile
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOHAVEN LTD. | Chief Tech/Sci/R&D Officer | - |
Portage Pharmaceutical Ltd.
 Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The private company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Chief Operating Officer | - |
Eerdere bekende functies van Kimberly Gentile
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Director/Board Member | 03-10-2022 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-02-2014 |
| SCIREX Corp. | Corporate Officer/Principal | 01-06-2000 |
Opleiding van Kimberly Gentile
| Salem State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| BIOHAVEN LTD. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| SCIREX Corp. | Commercial Services |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
Portage Pharmaceutical Ltd.
Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The private company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Commercial Services |
